The Israeli-based medical device company addresses the high failure rates of thermal ablation procedures, which have a market size in the billions but lack real-time monitoring capabilities. Their system performs real-time monitoring and control of tissue destruction by ablation devices, allowing physicians to predict the progression of tissue destruction during the procedure. This technology offers added value to patients, physicians, and insurance companies by increasing the success rate of minimally invasive and cost-effective procedures for tumor destruction, heart arrhythmia, blood pressure treatments, and more.